We believe SVT-001 provides true hope to prevent the almost inevitable vision loss caused by this devastating condition ...

In this expert perspective from Retina 2026, Ehsan Rahimy, MD, a retina specialist at Palo Alto Medical Foundation, discussed promising advancements in the treatment of retinal diseases.Rahimy said th ...

NYU Grossman School of Medicine's Department of Ophthalmology has appointed Dimitra Skondra, MD, PhD, a distinguished retinal specialist and translational researcher, as vice chair of research. With a ...

"Monogenic" diseases, triggered by mutations in just one gene, may actually be more complex than scientists thought.

Scientists at the Jules Stein Eye Institute at the David Geffen School of Medicine at UCLA have discovered that certain retinal cells can rewire themselves when vision begins to deteriorate in ...

Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first ...

BioAge Labs (NASDAQ:BIOA) outlined its strategy and near-term clinical plans at Oppenheimer’s 36th Annual Life Science Conference, emphasizing its focus on using human aging biology to develop ...

Newcells provides a reliable and quick in vitro safety and efficacy service for evaluating novel compounds for retinal therapy with complex human retinal organoid or retinal pigment epithelium (RPE) ...

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "AAV for the Hereditary Retinal Diseases - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers a thorough ...